Rucha Patil on WFH Humanitarian Aid Program in India
Rucha Patil, Scientist, Department of Haemostasis and Thrombosis, ICMR- National Institute of Immunohaematology, shared a proud post on LinkedIn:
”The World Federation of Hemophilia Humanitarian Aid Department, in collaboration with Hemophilia Federation (India) organized a valuable workshop in Delhi, India, on 12-13 July 2025 focused on the effective use of Extended Half-Life (EHL) treatment products. The workshop aimed to enhance the utilization of EHL donations and provide training to treaters from recipient Hemophilia Treatment Centres (HTCs) across India.
We are proud to share that our KEM-ICMR-NIIH HTC been able to initiate low-dose Immune Tolerance Induction (ITI) using EHL products, thanks to the generous support from WFH and achieve a 60% success rate—an outcome we had the opportunity to present at this important workshop.
We are deeply grateful to WFH for their continued support and impactful donations. Their efforts are making a real difference in the lives of our patients.”

Stay updated on the latest news in the field of hemophilia with Hemostasis Today.
-
Feb 2, 2026, 16:52Aravind Palraj: Young Stroke is Never Just Stroke
-
Feb 2, 2026, 16:48Seyed Mohsen Jahromi Moghadam: Antithrombotic Therapy After Transcatheter Structural Heart Interventions
-
Feb 2, 2026, 16:45Shashank Joshi: Switching Among Oral Anticoagulants
-
Feb 2, 2026, 16:40Zeinab Mubarak: How do Women Benefit from Menstrual Blood?
-
Feb 2, 2026, 16:23Ignacio Diaz Lorenzo: Reflecting on the Management of Acute Pulmonary Embolism
-
Feb 2, 2026, 16:18Tareq Abadl: Persistent Anti-β2GPI IgG Is Not a Coincidence – It’s Pathology
-
Feb 2, 2026, 16:06Christian Heiss։ When Diabetes and PAD Overlap, Cardiovascular and Limb Risks Rise
-
Feb 2, 2026, 16:02Shiny K. Kajal: Platelet Transfusion Is a Therapy – Not a Reflex
-
Feb 2, 2026, 15:37Rana Saifi: An Exciting Time for the Bleeding Disorders Community